AI assistant
Sending…
LIGAND PHARMACEUTICALS INC — Director's Dealing 2016
May 20, 2016
31289_dirs_2016-05-19_87e86d8b-0e0b-4e9c-a9ff-5099f56afb8c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2016-05-18
Reporting Person: Herman Melanie J (Director of Accounting)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-18 | Common Stock | S | 334.0 | $120.5 | Disposed | 3297 | Direct |
More from LIGAND PHARMACEUTICALS INC
Proxy Solicitation & Information Statement
2026
May 18
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
May 1
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 27
Annual Report
2026
Apr 21